Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Guidance for Industry DRAFT GUIDANCE
NonrulemakingOtherFDA-2019-D-4964-0002
Comments
0
Awaiting comments
Deadline
Closed on Mar 20, 2020
Closed Mar 20, 2020
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Dec 20, 2019
- Comment period
- Dec 20, 2019 – Mar 20, 2020
- Agency
- Food and Drug Administration (FDA)
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.